HCA Healthcare, Inc. (NYSE:HCA) is Diamond Hill Capital Management Inc.’s 8th Largest Position

Diamond Hill Capital Management Inc. lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.8% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 1,568,712 shares of the company’s stock after selling 61,947 shares during the quarter. HCA Healthcare makes up about 2.2% of Diamond Hill Capital Management Inc.’s investment portfolio, making the stock its 8th biggest position. Diamond Hill Capital Management Inc.’s holdings in HCA Healthcare were worth $503,996,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its position in shares of HCA Healthcare by 0.4% during the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock worth $5,666,569,000 after buying an additional 60,304 shares during the last quarter. Sanders Capital LLC raised its position in HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after purchasing an additional 456,738 shares during the last quarter. Wellington Management Group LLP raised its position in HCA Healthcare by 1.7% in the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after purchasing an additional 170,560 shares during the last quarter. Royal Bank of Canada raised its position in HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after purchasing an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors raised its position in HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the sale, the senior vice president now owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the completion of the sale, the senior vice president now owns 40,449 shares of the company’s stock, valued at $14,569,729.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 over the last 90 days. 1.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Wells Fargo & Company upped their price target on shares of HCA Healthcare from $315.00 to $365.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 30th. UBS Group boosted their price objective on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Robert W. Baird started coverage on shares of HCA Healthcare in a research note on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective on the stock. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Oppenheimer upped their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $359.89.

HCA Healthcare Trading Up 0.8 %

Shares of HCA stock opened at $394.68 on Friday. The firm’s 50-day simple moving average is $362.19 and its 200-day simple moving average is $338.12. The firm has a market cap of $101.86 billion, a P/E ratio of 19.67, a PEG ratio of 1.46 and a beta of 1.67. HCA Healthcare, Inc. has a 1-year low of $215.96 and a 1-year high of $403.05. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The firm had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $4.29 EPS. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 22.46 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.67%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.